Depodur vs Fentanyl Infusion for Post-C/S Analgesia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00762554|
Recruitment Status : Unknown
Verified September 2008 by Goodman, Evan, M.D..
Recruitment status was: Not yet recruiting
First Posted : September 30, 2008
Last Update Posted : September 30, 2008
|Condition or disease||Intervention/treatment||Phase|
|Analgesia||Drug: Depodur Drug: Fentanyl||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||A Comparison of Single Dose Depodur With Fentanyl Infusion for Post-Cesarean Section Analgesia|
|Study Start Date :||October 2008|
|Estimated Primary Completion Date :||June 2009|
|Estimated Study Completion Date :||June 2009|
Active Comparator: 1
Epidural Depodur after epidural lidocaine
Depodur 10mg given epidurally at end of cesarean section.
Active Comparator: 2
Epidural Depodur after spinal bupivacaine
Depodur 10mg given epidurally at end of cesarean section after patient received spinal bupivacaine at the beginning of the case.
Active Comparator: 3
Epidural fentanyl infusion after epidural lidocaine or spinal bupivacaine
Epidural fentanyl infusion started after epidural lidocaine or spinal bupivacaine used for the cesarean section.
- Degree of analgesia (measured on a 10-point scale) [ Time Frame: 48 hours post-operatively ]
- Frequency of minor side effects, such as pruritis or nausea. [ Time Frame: 48 hours postoperatively ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00762554
|United States, Ohio|
|University Hospitals Case Medical Center|
|Cleveland, Ohio, United States, 44106|
|Contact: Evan Goodman, MD 216-844-5300 email@example.com|
|Contact: Susan Dumas, MD 2168447330 firstname.lastname@example.org|
|Principal Investigator: Evan Goodman, MD|